Research Overview: Varenismart 0.
Varenicline is a quinoxaline-derived nicotinic acetylcholine receptor partial agonist that demonstrates selective binding activity at α4β2 neuronal nicotinic receptor subtypes. This synthetic compound exhibits dual pharmacological properties, functioning as both a partial agonist and competitive antagonist depending on the presence of nicotine in research environments. Manufactured by Healing Pharma, Varenismart 0.5mg provides researchers with a standardised preparation for investigating nicotinic receptor modulation mechanisms. The compound’s unique molecular structure allows researchers to examine receptor binding kinetics and signal transduction pathways in controlled laboratory settings. Studies at Stroid UK Shop have utilised varenicline to investigate neuroplasticity, synaptic transmission, and dopaminergic pathway interactions.
Laboratory Applications
Research applications for varenicline encompass neuropharmacological studies examining nicotinic receptor function, addiction neurobiology investigations, and dopaminergic system research. Laboratory protocols employ this compound to evaluate receptor desensitisation patterns, agonist-antagonist binding competition, and downstream signalling cascade effects. Researchers investigating nicotinic receptor modulators utilise varenicline in comparative studies with other cholinergic compounds. Cell culture experiments examine the compound’s effects on neurotransmitter release mechanisms and synaptic plasticity models. Advanced research facilities investigate varenicline’s interactions with reward pathway circuitry, examining its effects on dopamine release in ventral tegmental area preparations. Studies also explore the compound’s influence on cognitive performance markers in various research paradigms, particularly those examining attention and memory consolidation processes.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Varenicline Tartrate |
| Strength | 0.5mg per unit |
| Manufacturer | Healing Pharma |
| CAS Number | 249296-44-4 |
| Molecular Formula | C₁₃H₁₃N₃ |
| Molecular Weight | 211.26 g/mol |
| Storage Conditions | Store below 25°C, protect from moisture |
| Shelf Life | As per manufacturer specifications |
Researchers working with selective receptor modulators and bioactive compounds should verify chemical specifications with their institutional protocols before commencing experimental procedures.
Research Compliance
This product is manufactured exclusively for in-vitro research applications and is not intended for human consumption, clinical use, or therapeutic purposes. Researchers must ensure compliance with institutional review board guidelines and laboratory safety protocols when handling this compound. Proper laboratory ventilation, personal protective equipment, and waste disposal procedures are essential for safe research practices. All studies should be conducted under appropriate scientific supervision with adherence to relevant research ethics frameworks.
